PharmaReports: Cancer Immunotherapy
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
This channel is dedicated to immunotherapy approaches to cancer such as interleukins and other immunostimulators. Oncolytic viruses and cell based therapies are also included in this channel. Most reports included in this channel are technological in approach.
Showing results 51 - 100 of 130
- Drug Discovery Tools for High-Content Analysis
- Personalized Medicine
- Colorectal Cancer Drug Pipeline Update 2007
- Stakeholder Opinions: Primary Brain Cancer
- Commercial Insight: Top 20 Cancer Therapy Brands - Sales of targeted therapies
- Melanoma Therapeutics: Which Strategy Will Take Us There?
- Apoptosis: Promise or deception?
- Breast Cancer Drug Pipeline Update 2007
- Breast Cancer - Therapeutic And Competitive Insights
- Cancer Vaccines Fantasy or Future?
- Immunotherapy in Oncology: Gaining Momentum
- MYELODYSPLASTIC SYNDROME - Therapy Area Pipeline Report
- LEUKEMIA - Therapy Area Pipeline Report
- BREAST CANCER - Therapy Area Pipeline Report
- GASTRIC CANCER - Therapy Area Pipeline Report
- HEAD AND NECK CANCER - Therapy Area Pipeline Report
- KIDNEY CANCER - Therapy Area Pipeline Report
- LIVER CANCER - Therapy Area Pipeline Report
- MELANOMA and SKIN CANCER - Therapy Area Pipeline Report
- MULTIPLE MYELOMA - Therapy Area Pipeline Report
- NON - HODGKIN LYMPHOMA (NHL) - Therapy Area Pipeline Report
- OVARIAN CANCER - Therapy Area Pipeline Report
- PANCREATIC CANCER - Therapy Area Pipeline Report
- PROSTATE CANCER - Therapy Area Pipeline Report
- Innovative and Targeted Cancer Therapies: Key technologies, new applications and leading players
- Decoding Big Pharmas R&D Strategy in Oncology
- Monoclonal Antibodies: strategic analysis of the mAb market out to 2012
- Pipeline Insight: Cancer Overview - Increasing diversity offers both high risk and reward
- The Future of Biosimilars: Key opportunities & emerging therapies
- Biomarker Technology Platforms for Cancer Diagnoses and Therapies
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
- Pipeline Insight: Molecular Targeted Cancer Therapies
- Stakeholder Insight: Renal Cancer - Targeted therapies rapidly take hold of market
- Biosimilars Series: Strategic issues - Potential remains uncertain
- Immunomodulators: Therapeutic Needs, Pipelines and Prospects
- Translational Medicine in Biopharmaceutical Research and Development
- Licensing Strategies - Current Pharmaceutical Licensing Trends
- Pediatric Drugs - the Worldwide Market
- BAFF (BLys) and APRIL: Emerging Targets for autoimmune disease & Cancer Therapeutics
- Stakeholder Opinions: Malignant Melanoma - High Hurdles, High Rewards, Are Vaccines Only Skin Deep?
- The Future of Monoclonal Antibody Therapeutics: Innovation in antibody engineering, key growth strategies and forecasts to 2011
- The World Market for Vaccines
- The Emerging Cancer Vaccine Market
- Monoclonal Antibodies in Cancer Therapy: Emerging Products and Markets
- Immunomodulators in Cancer Therapy: Emerging Products and Markets
- Gene Expression Profiling Markets
- Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments: World Market
- Myelodysplastic Syndromes - First approvals spur interest in niche market
- Non-Hodgkin's Lymphoma - Is there room to emulate Rituxan's success?
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development